ArticleScientific reports2022

Author Correction: Phase I trial of Bermekimab with nanoliposomal irinotecan and 5‑fuorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma.

Jun Gong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.